# FDA Inspection 991421 - Ruwanti Gunawardane, M.D. - May 16, 2016

Source: https://www.keypedia.com/records/fda_inspections/ruwanti-gunawardane-md/b57fd0c7-5829-4bda-8aea-4d3ccc7a1a01
Source feed: FDA_Inspections

> FDA Inspection 991421 for Ruwanti Gunawardane, M.D. on May 16, 2016. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 991421
- Company Name: Ruwanti Gunawardane, M.D.
- Inspection Date: 2016-05-16
- Classification: Official Action Indicated (OAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/ruwanti-gunawardane-md/5b99a050-9964-481b-bb93-9bbad71aa47a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c